Stocks
Biogen (BIIB) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 340.6% | 723.3% | 848.2% | 917.4% | 790.6% | 382.8% | |||
| Changes by years, y/y, % | +48pp | +383pp | +125pp | +69pp | -127pp | +22.0% | |||
Biogen. R&D/CAPEX, %
Biogen. R&D/CAPEX, changes, pp
Biogen (BIIB) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 840.5% | 875.6% | 317.3% | 1 038% | 195.3% | 382.8% | ||
| Changes by years, y/y, % | -89pp | +187pp | -480pp | +366pp | -645pp | |||
| Changes by quarters, q/q, % | +169pp | +35pp | -558pp | +720pp | -842pp | |||
